In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. - Pistrosch,F.; Passauer,J.; Fischer,S.; Fuecker,K.; Hanefeld,M.; Gross,P. (Diabetes Care, 2004)